News / USA

US Developing Radiation Sickness Drug

Ex-Rad could be used before or after exposure

Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.
Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.


Vidushi Sinha

The serious radiation leaks at Japan's damaged Fukushima-Daiichi nuclear power plant have reawakened public fears about radiation sickness. But what if there were a drug that could not only protect people from dangerous levels of radiation exposure but also heal those actually exposed to damaging nuclear radiation?

Researchers say they are developing such a drug - one that can both prevent and repair human cell damage from all types of radiation exposure.

Such a healing medication has the potential to lessen panic and fear generated by catastrophic reactor accidents. Plant workers trying to make repairs near a crippled reactor's radioactive core might be less fearful if they could take a pill to repair their own radiation-damaged cells.

Ramesh Kumar, the CEO of a U.S. drug research firm called Onconova, says his company has just such a wonder drug in the works.

The company has been collaborating on the drug, called Ex-Rad, with scientists at a U.S. Defense Department research laboratory. Kumar says early animal trials have been promising.

“Ex-Rad is a drug which is effective in saving a cell damaged by radiation," he says, "and we have found that it can be given in advance of exposure to radiation up to a day ahead or it can be given up to a day after the exposure to radiation.”

There are existing antidotes for radiation exposure which have been approved by the federal Food and Drug Administration (FDA). Potassium iodide, also known as the radiation pill, prevents the body's absorption of the radioactive iodine present in reactor emissions. For a person poisoned by radioactive isotopes such as plutonium and cesium - types of radiation being released from the Fukushima reactors - FDA-approved drugs such as Prussian Blue capsules can quickly flush radioactive elements from the body. However, right now there are no drugs specifically for treating radiation sickness itself.

The Armed Forces Radiobiology Research Institute has been leading the Pentagon's quest for a more effective antidote to radiation sickness, which has a wide range of symptoms.

“The symptoms of acute radiation sickness will be just exactly like a terrible flu," says Col. Andrew Huff, a spokesman for the research institute. "The person would have headache. They would feel very tired. They would have little bit of fever. They might have some vomiting at higher doses all of this and more but at survivable doses it would come on within 24 to 36 hours."

According to Huff, the body loses its platelet and neutrophil supply and people can eventually die of bleeding. He says the Pentagon's search for radiation sickness treatments is intensifying.

“The other more vexing problem, the one that we really have to worry about for larger numbers of people - if there were nuclear terrorism - is how much external ionizing penetrating radiation a person would get after a nuclear detonation."

To combat such a crisis - or to treat people exposed to radiation from a damaged nuclear reactor - the Department of Defense and Onconova have collaborated on the development of Ex-Rad.

“FDA has devised a development path for drugs like Ex-Rad which involves clinical trials, animal studies, and additional controls for manufacturing and we are in the process of completing these studies," says Kumar, whose company is developing Ex-Rad. "We started this process in 2008 under and FDA's Investigational New Drug Exemption. We have carried out clinical studies in human subjects for safety and we are in the process of continuing to do animal efficacy studies so once all of these studies are completed we can get an approval for specific indication. It could be prophylactic use before - or after - exposure.  It could be injectable or oral.”

Kumar says Ex-Rad won't be available for at least another two or three years. In the meantime, government officials warn the public to be cautious about the growing number of claims being made on the Internet for anti-radiation drugs that purport to be miracle cures.

You May Like

Video In US, Columbus Day Still Generates Controversy

Holiday marks date Columbus discovered Americas, but some are offended by legacy because he enslaved many natives he encountered More

Video Through Sports, Austria Tries to Give Migrants Traction

With 85,000 people expected to claim asylum in Austria this year, its government has made integration through joint physical activities a key objective More

Video Kickboxing Champion Shares Sport With Young Migrants

Pouring into Europe by hundreds of thousands, some migrants, especially youngsters, are finding sports a way to integrate into new host countries More

This forum has been closed.
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Amnesty Accuses Saudi Coalition of ‘War Crimes’ in Yemeni
Henry Ridgwell
October 12, 2015 4:03 PM
The human rights group Amnesty International has accused the Saudi-led coalition of war crimes in airstrikes against Houthi rebels in Yemen. Henry Ridgwell reports the group says hundreds of civilians have been killed in strikes on residential areas.

Video Amnesty Accuses Saudi Coalition of ‘War Crimes’ in Yemen

The human rights group Amnesty International has accused the Saudi-led coalition of war crimes in airstrikes against Houthi rebels in Yemen. Henry Ridgwell reports the group says hundreds of civilians have been killed in strikes on residential areas.

Video No Resolution in Sight to US House Speaker Drama

Uncertainty grips the U.S. Congress, where no consensus replacement has emerged to succeed Republican House Speaker John Boehner after his surprise resignation announcement. Half of Congress is effectively leaderless weeks before America risks defaulting on its national debt and enduring another partial government shutdown.

Video New Art Exhibit Focuses on Hope

Out of struggle and despair often comes hope. That idea is behind a new art exhibit at the American Visionary Art Museum in Baltimore, Maryland. "The Big Hope Show" features 25 artists, some of whom overcame trauma and loss. VOA’s Deborah Block reports.

Video Columbus Day Still Generates Controversy as US Holiday

The second Monday of October is Columbus Day in the United States, honoring explorer Christopher Columbus and his discovery of the Americas. The achievement is a source of pride for many, but for some the holiday is marked by controversy. Adrianna Zhang has more.

Video Anger Simmers as Turks Begin to Bury Blast Victims

The Turkish army carried out new air strikes on Kurdistan Workers Party (PKK) targets on Sunday, a day after the banned group announced a unilateral cease fire. The air raids apparently are in retaliation for the Saturday bombing in Turkey's capital Ankara that killed at least 95 people and wounded more than 200 others. But as Zlatica Hoke reports, there are suspicions that Islamic State is involved.

Video Bombings a Sign of Turkey’s Deep Troubles

Turkey has begun a three-day period of mourning following Saturday’s bomb attacks in the capital, Ankara, that killed nearly 100 people. With contentious parliamentary elections three weeks away, the attacks highlight the challenges Turkey is facing as it struggles with ethnic friction, an ongoing migrant crisis, and growing tensions with Russia. VOA Europe correspondent Luis Ramirez reports.

Video Afghanistan’s Progress Aided by US Academic Center

Recent combat in Afghanistan has shifted world attention back to the central Asian nation’s continuing civil war and economic challenges. But, while there are many vexing problems facing Afghanistan’s government and people, a group of academics in Omaha, Nebraska has kept a strong faith in the nation’s future through programs to improve education. VOA’s Greg Flakus has more from Omaha, Nebraska.

Video House Republicans in Chaos as Speaker Favorite Withdraws

The Republican widely expected to become the next speaker of the House of Representatives shocked his colleagues Thursday by announcing he was withdrawing his candidacy. The decision by Majority Leader Kevin McCarthy means the race to succeed retiring Speaker John Boehner is now wide open. VOA National Correspondent Jim Malone reports.

Video German, US Officials Investigate Volkswagen

German officials have taken steps to restore some of the reputation their car industry has lost after a recent Volkswagen diesel emissions scandal. Authorities have searched Volkswagen headquarters and other locations in an effort to identify the culprits in the creation of software that helps cheat on emission tests. Meanwhile, a group of lawmakers in Washington held a hearing to get to the bottom of the cheating strategy that was first discovered in the United States. Zlatica Hoke reports.

Video Why Are Gun Laws So Hard for Congress to Tackle?

Since taking office, President Barack Obama has spoken out or issued statements about 15 mass shootings. The most recent shooting, in which 10 people were killed at a community college, sparked outrage over the nation's gun laws. But changing those laws isn't as easy as many think. VOA's Carolyn Presutti reports.

Video In 'He Named Me Malala,' Guggenheim Finds Normal in Extraordinary

Davis Guggenheim’s documentary "He Named Me Malala" offers a probing look into the life of 18-year-old Malala Yousafsai, the Pakistani teenager who, in 2012, was shot in the head by the Taliban for standing up for her right to education in her hometown in Pakistan's Swat Valley. Guggenheim shows how, since then, Malala has become a symbol not as a victim of brutal violence, but as an advocate for girls’ education throughout the world. VOA’s Penelope Poulou has more.

Video Paintable Solar Cells May Someday Replace Silicon-Based Panels

Solar panels today are still factory-manufactured, with the use of some highly toxic substances such as cadmium chloride. But a researcher at St. Mary’s College, Maryland, says we are close to being able to create solar panels by painting them on a suitable surface, using nontoxic solutions. VOA’s George Putic reports.

VOA Blogs